View up-to-date information on Arrowhead Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 25 Apr 2022 | Visirna Therapeutics Enters into Licensing Agreement with Arrowhead Pharma | Licensing Agreement |
Visirna Therapeutics Inc
|
Arrowhead Pharmaceuticals Inc |
| 25 Apr 2022 | Arrowhead Pharma and Vivo Capital Form Joint Venture | Partnership |
Visirna Therapeutics Inc
|
Arrowhead Pharmaceuticals Inc
Vivo Capital LLC
|
| 22 Nov 2021 | GlaxoSmithKline Enters into Licensing Agreement with Arrowhead Pharma | Licensing Agreement |
GSK plc
|
Arrowhead Pharmaceuticals Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward